Drawing for EPIZQA

USPTO serial 79354334

EPIZQA

Reviewed by CopyMark Law Group

Reg. 7185271Status 700Registered
Filing date
Status date
Registration date
Oct 10, 2023
Examiner
BARRETT, LEAH N
Law office
TMEG LAW OFFICE 106

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EPIZQA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; antidiabetic preparations; human vaccine preparations; preparations for medical use, namely, preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of diseases of the metabolic system; dietary supplementsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 2, 2023GPNXNOTIFICATION PROCESSED BY IB
Nov 13, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB
Nov 13, 2023FIMPFINAL DISPOSITION PROCESSED
Nov 9, 2023GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB
Oct 10, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 25, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 5, 2023NPUBNOTICE OF PUBLICATION
Jun 22, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2023DOCKASSIGNED TO EXAMINER
Nov 22, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Nov 16, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 14, 2022LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 3, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance